Literature DB >> 9563877

Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast.

K M Alle1, S M Henshall, A S Field, R L Sutherland.   

Abstract

The cell cycle regulatory gene cyclin D1 is a candidate oncogene in breast cancer. It is overexpressed in 30-50% of invasive primary breast cancers and plays a key role in mediating mitogenic responses to steroids and growth factors in breast cancer cells in vitro. Because the role of cyclin D1 in the proliferative and early noninvasive stages of breast cancer is largely unknown, we examined normal breast epithelium (NBE), proliferative disease (PD), ductal carcinoma in situ (DCIS), and invasive carcinoma (IC) to evaluate the timing and possible importance of cyclin D1 expression in the development of breast cancer. Using immunohistochemistry, we examined cyclin D1 protein expression in 471 breast tissue samples. A quantitative scoring system for immunohistochemistry based on percentage of positive cells was developed that correlated with Western blot analysis of antigen concentration in paired samples (r2 = 0.91, P = 0.003). A sample was considered positive if >5% of relevant epithelial cells demonstrated nuclear staining. Cyclin D1 positivity was observed in 11.7% (7 of 60) samples of NBE, 25% (11 of 44) of PD without atypia, 39.4% (13 of 33) of atypical ductal hyperplasia, 43.6% (17 of 39) of low-grade DCIS, 47.9% (23 of 48) of high-grade DCIS, and 48.3% (99 of 205) of IC. Cyclin D1 expression was significantly higher in PD than NBE (P = 0.006) and in DCIS than PD (P = 0.038). There was no significant increase from DCIS to IC (P = 0.52). The increase in cyclin D1 expression in the overall progression from NBE to IC was also highly significant (P = 0.0001). Therefore, cyclin D1 expression was detected at levels significantly greater than in NBE in the earliest proliferative epithelial lesions of the breast with a further significant increase accompanying the progression to any form of cancer. This suggests that overexpression of cyclin D1 protein is important at the earliest stages of breast oncogenesis and continues to have a crucial role throughout the development of malignancy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563877

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  22 in total

1.  Localised breast cancers may have systemic influences on skin and hair.

Authors:  James S Lawson; Dinh D Tran
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

2.  Effects of short-term estrogen treatment on the progression of N-methyl-N-nitrosourea-induced premalignant mammary lesions in female Lewis rats.

Authors:  Takashi Yuri; Yen-Chang Lai; Sayaka Kanematsu; Maki Kuwata; Katsuhiko Yoshizawa; Airo Tsubura
Journal:  Med Mol Morphol       Date:  2011-09-16       Impact factor: 2.309

3.  Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.

Authors:  Jessica A Miller; Kirk Pappan; Patricia A Thompson; Elizabeth J Want; Alexandros P Siskos; Hector C Keun; Jacob Wulff; Chengcheng Hu; Julie E Lang; H-H Sherry Chow
Journal:  Cancer Prev Res (Phila)       Date:  2014-11-11

4.  Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.

Authors:  Y Takano; Y Kato; P J van Diest; M Masuda; H Mitomi; I Okayasu
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 5.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

6.  Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.

Authors:  A V Biankin; S A Biankin; J G Kench; A L Morey; C-S Lee; D R Head; R P Eckstein; T B Hugh; S M Henshall; R L Sutherland
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

7.  Expression of cell cycle proteins in male breast carcinoma.

Authors:  Rani Kanthan; Isabella Fried; Theresa Rueckl; Jenna-Lynn Senger; Selliah Chandra Kanthan
Journal:  World J Surg Oncol       Date:  2010-02-12       Impact factor: 2.754

Review 8.  Cyclins and breast cancer.

Authors:  Robert L Sutherland; Elizabeth A Musgrove
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

9.  Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer.

Authors:  Jessica A Miller; Julie E Lang; Michele Ley; Ray Nagle; Chiu-Hsieh Hsu; Patricia A Thompson; Catherine Cordova; Amy Waer; H-H Sherry Chow
Journal:  Cancer Prev Res (Phila)       Date:  2013-04-03

10.  Differential expressions of cyclin D1 associated with better prognosis of cancers of ampulla of Vater.

Authors:  Ming-Chug Chang; Yu-Ting Chang; Chia-Tung Sun; Yen-Feng Chiu; Jaw-Town Lin; Yu-Wen Tien
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.